Integra Lifesciences Holdings (IART) FCF Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly FCF Margin of 1.29% in Q1 2026, down 3.72% quarter-over-quarter from 1.24% in Q4 2025, and up 921.0% year-over-year from 0.13% in Q1 2025.
Integra Lifesciences Holdings' FCF Margin history runs 18 years deep, the most recent figure standing at 1.29% for Q1 2026.
- In Q1 2026, FCF Margin rose 921.0% year-over-year to 1.29%; the TTM figure through Mar 2026 stood at 0.25% (up 120.0% YoY), while the FY2025 annual figure was 1.9%, down 345.0% from the prior year.
- FCF Margin came in at 1.29% for Q1 2026 at Integra Lifesciences Holdings, down from 1.24% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 17.81% in Q4 2022 to a low of 10.5% in Q1 2025.
- A 5-year average of 4.22% and a median of 3.34% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 1178 bps in 2023 and surged 921 bps in 2026, its largest moves.
- Integra Lifesciences Holdings' FCF Margin stood at 17.81% in 2022, then slumped by 52 bps to 8.62% in 2023, then slumped by 45 bps to 4.78% in 2024, then tumbled by 126 bps to 1.24% in 2025, then dropped by 4 bps to 1.29% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 1.29%, 1.24%, and 6.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | -1.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29% |
| Dec 31, 2025 | -1.24% |
| Sep 30, 2025 | 6.40% |
| Jun 30, 2025 | -2.70% |
| Mar 31, 2025 | -10.50% |
| Dec 31, 2024 | 4.78% |
| Sep 30, 2024 | -1.88% |
| Jun 30, 2024 | 2.56% |
| Mar 31, 2024 | 0.08% |
| Dec 31, 2023 | 8.62% |
| Sep 30, 2023 | 3.58% |
| Jun 30, 2023 | 3.34% |
| Mar 31, 2023 | 3.27% |
| Dec 31, 2022 | 17.81% |
| Sep 30, 2022 | 15.36% |
| Jun 30, 2022 | 14.35% |
| Mar 31, 2022 | 9.30% |
| Dec 31, 2021 | 10.32% |
| Sep 30, 2021 | 19.51% |
| Jun 30, 2021 | 21.71% |
| Mar 31, 2021 | 17.33% |
| Dec 31, 2020 | 18.48% |
| Sep 30, 2020 | 16.99% |
| Jun 30, 2020 | 10.01% |
| Mar 31, 2020 | 1.21% |
| Dec 31, 2019 | 16.95% |
| Sep 30, 2019 | 13.36% |
| Jun 30, 2019 | 8.04% |
| Mar 31, 2019 | 3.72% |
| Dec 31, 2018 | 4.44% |
| Sep 30, 2018 | 17.11% |
| Jun 30, 2018 | 4.43% |
| Mar 31, 2018 | 7.32% |
| Dec 31, 2017 | -0.58% |
| Sep 30, 2017 | 13.43% |
| Jun 30, 2017 | 5.69% |
| Mar 31, 2017 | 7.61% |
| Dec 31, 2016 | -5.74% |
| Sep 30, 2016 | 15.90% |
| Jun 30, 2016 | 11.96% |
| Mar 31, 2016 | 5.97% |
| Dec 31, 2015 | 5.20% |
| Sep 30, 2015 | 6.30% |
| Jun 30, 2015 | 14.37% |
| Mar 31, 2015 | 12.98% |
| Dec 31, 2014 | -3.19% |
| Sep 30, 2014 | 12.48% |
| Jun 30, 2014 | 3.56% |
| Mar 31, 2014 | -0.04% |
| Dec 31, 2013 | 3.12% |
| Sep 30, 2013 | 8.24% |
| Jun 30, 2013 | -5.21% |
| Mar 31, 2013 | -1.53% |
| Dec 31, 2012 | -13.09% |
| Sep 30, 2012 | 3.90% |
| Jun 30, 2012 | -5.69% |
| Mar 31, 2012 | 11.17% |
| Dec 31, 2011 | 10.64% |
| Sep 30, 2011 | 5.71% |
| Jun 30, 2011 | 8.98% |
| Mar 31, 2011 | 8.47% |
| Dec 31, 2010 | 5.25% |
| Sep 30, 2010 | 12.02% |
| Jun 30, 2010 | 0.96% |
| Mar 31, 2010 | 19.73% |
| Dec 31, 2009 | 19.48% |
| Sep 30, 2009 | 13.17% |